Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Trinity Biotech (TRIB) Assets (2016 - 2025)

Trinity Biotech's Assets history spans 17 years, with the latest figure at $105.2 million for Q4 2025.

  • On a quarterly basis, Assets rose 1.82% to $105.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $105.2 million, a 1.82% increase, with the full-year FY2025 number at $105.2 million, up 1.82% from a year prior.
  • Assets hit $105.2 million in Q4 2025 for Trinity Biotech, up from $99.6 million in the prior quarter.
  • Over the last five years, Assets for TRIB hit a ceiling of $136.0 million in Q1 2021 and a floor of $59.4 million in Q4 2023.
  • Historically, Assets has averaged $99.0 million across 5 years, with a median of $98.8 million in 2022.
  • Biggest five-year swings in Assets: crashed 35.47% in 2023 and later surged 73.79% in 2024.
  • Tracing TRIB's Assets over 5 years: stood at $118.9 million in 2021, then dropped by 22.53% to $92.1 million in 2022, then plummeted by 35.47% to $59.4 million in 2023, then surged by 73.79% to $103.3 million in 2024, then grew by 1.82% to $105.2 million in 2025.
  • Business Quant data shows Assets for TRIB at $105.2 million in Q4 2025, $99.6 million in Q2 2025, and $103.3 million in Q4 2024.